Jw Pharmac
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam steri… Read more
Jw Pharmac (001060) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.132x
Based on the latest financial reports, Jw Pharmac (001060) has a cash flow conversion efficiency ratio of 0.132x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.92 Billion) by net assets (₩354.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jw Pharmac - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Jw Pharmac's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jw Pharmac Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jw Pharmac ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sichuan Goldstone Orient New Material Equipment Co Ltd
SHE:300434
|
0.063x |
|
Matrix Service Co
NASDAQ:MTRX
|
0.054x |
|
Village Farms International Inc
NASDAQ:VFF
|
0.084x |
|
Oncology Institute Inc
NASDAQ:TOI
|
1.029x |
|
Upstream Bio, Inc.
NASDAQ:UPB
|
-0.059x |
|
Jinan High tech Development Co Ltd
SHG:600807
|
-0.013x |
|
Turners Automotive Group Ltd
AU:TRA
|
-0.102x |
|
Genomictree Inc.
KQ:228760
|
-0.021x |
Annual Cash Flow Conversion Efficiency for Jw Pharmac (2001–2024)
The table below shows the annual cash flow conversion efficiency of Jw Pharmac from 2001 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩329.49 Billion | ₩79.39 Billion | 0.241x | -26.62% |
| 2023-12-31 | ₩265.44 Billion | ₩87.16 Billion | 0.328x | +30.59% |
| 2022-12-31 | ₩225.76 Billion | ₩56.76 Billion | 0.251x | +161.57% |
| 2021-12-31 | ₩188.54 Billion | ₩18.12 Billion | 0.096x | -68.37% |
| 2020-12-31 | ₩207.47 Billion | ₩63.05 Billion | 0.304x | +25.93% |
| 2019-12-31 | ₩230.09 Billion | ₩55.53 Billion | 0.241x | +20.47% |
| 2018-12-31 | ₩260.11 Billion | ₩52.11 Billion | 0.200x | +62.17% |
| 2017-12-31 | ₩270.78 Billion | ₩33.45 Billion | 0.124x | +406.54% |
| 2016-12-31 | ₩276.31 Billion | ₩6.74 Billion | 0.024x | +231.67% |
| 2015-12-31 | ₩225.41 Billion | ₩-4.17 Billion | -0.019x | -156.95% |
| 2014-12-31 | ₩223.83 Billion | ₩7.28 Billion | 0.033x | -65.14% |
| 2013-12-31 | ₩200.74 Billion | ₩18.72 Billion | 0.093x | -76.23% |
| 2012-12-31 | ₩163.66 Billion | ₩64.21 Billion | 0.392x | +1233.92% |
| 2006-12-31 | ₩172.48 Billion | ₩5.07 Billion | 0.029x | -95.00% |
| 2005-12-31 | ₩119.44 Billion | ₩70.25 Billion | 0.588x | +367.61% |
| 2004-12-31 | ₩119.39 Billion | ₩15.02 Billion | 0.126x | -16.92% |
| 2003-12-31 | ₩112.60 Billion | ₩17.05 Billion | 0.151x | -46.93% |
| 2002-12-31 | ₩100.72 Billion | ₩28.74 Billion | 0.285x | -43.68% |
| 2001-12-31 | ₩88.92 Billion | ₩45.04 Billion | 0.507x | -- |